Growth factors in pancreatic health and disease

Pancreatology

Volumn 1, Issue 4, 2001, Pages 343-355

  Balaz, Peter ^a   Friess, Helmut ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chronic pancreatitis; Growth factor receptors; Growth factors; Pancreatic cancer

Indexed keywords

GROWTH PROMOTOR; PANCRELIPASE;

ANIMAL; CHRONIC DISEASE; HUMAN; METABOLISM; PANCREAS DISEASE; PANCREAS TUMOR; PANCREATITIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CHRONIC DISEASE; GROWTH SUBSTANCES; HUMANS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PANCREATITIS; PANCRELIPASE;

EID: 0035553423     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055833     Document Type: Conference Paper

References (162)

1. Sarles H, Bernard JP, Johnson C, Chir M: Pathogenesis and epidemiology of chronic pancreatitis. Annu Rev Med 1989;40:453-468.
2. DiMagno EP, Layer P, Clain JE: Chronic pancreatitis; in Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Exocrine Pancreas: Biology, Pathobiology, and Diseases. New York, Raven Press, 1993, pp 665-706.
3. DiMagno EP: A short, eclectic history of exocrine pancreatic insufficiency and chronic pancreatitis. Gastroenterology 1993;104:1255-1262.
4. Friess H, Müller M, Ebert M, Büchler MW: Chronic pancreatitis with inflammatory enlargement of the pancreatic head. Zentralbl Chir 1995;120:292-297.
5. Bockman DE: Surgical anatomy of the pancreas and adjacent structures; in Beger HG, Büchler M, Malfertheiner P (eds): Standards in Pancreatic Surgery. New York, Springer, 1993, pp 1-9.
6. Oertel JE, Heffess CS, Oertel YC: Pancreas; in Sternberg SS (ed): Diagnostic Surgical Pathology. New York, Raven Press, 1989, chapt 32, pp 1057-1093.
7. Di Magno EP, Layer P, Clain JE: Chronic pancreatitis; in Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Pancreas. New York, Raven Press, 1993, pp 707-740.
8. Di Magno EP: Conservative management of chronic pancreatitis; in Beger HG, Büchler M, Malfertheiner P (eds): Standards in Pancreatic Surgery. New York, Springer, 1993, pp 325-331.
9. Bookman DE, Büchler M, Malfertheiner P, Beger HG: Analysis of nerves in chronic pancreatitis. Gastroenterology 1988;94:1459-1469.
10. Büchler M, Weihe E, Friess H, Malfertheiner P, Bockman E, Müller S, Nohr D, Beger HG: Changes in peptidergic innervation in chronic pancreatitis. Pancreas 1992;7:183-192.
11. Weihe E, Nohr D, Müller S, Büchler M, Friess H, Zentel HJ: The tachykinin neuroimmune connection in inflammatory pain. Ann NY Acad Sci 1991;632:283-295.
12. Sarles H, Dagorn JC, Giorgi D, Bernard JP: Renaming pancreatic stone protein as 'lithostathine'. Gastroenterology 1990;99:900-901.
13. Klöppel G, Maillet B: Pseudocysts in chronic pancreatitis: A morphological analysis of 57 resection specimens and 9 autopsy pancreata. Pancreas 1991;6:266-274.
14. Bordalo O, Bapista A, Dreiling D, Noronha M: Early pathomorphological pancreatic changes in chronic alcoholism; in Gyr KE, Singer MV, Sarles H (eds): Pancreatitis - Concepts and classification. Amsterdam, North Holland/Elsevier, 1984, No 642.
15. Braganza JM: Pancreatic disease: A casualty of hepatic 'detoxification'? Lancet 1983;8357: 1000-1003.
16. DiMagno EP: A short, eclectic history of exocrine pancreatic insufficiency and chronic pancreatitis. Gastroenterology 1993;104:1255-1262.
17. Di Sebastiano P, Fink T, Weihe E, Friess H, Innocenti P, Beger HG, Büchler MW: Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology 1997;112: 1648-1655.
18. Hunger RE, Mueller C, Z'graggen K, Friess H, Büchler MW: Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology 1997;112:1656-1663.
19. Friess H, Cantero D, Graber H, Tang WH, Guo X, Kashiwagi M, Zimmermann A, Gold L, Korc M, Büchler MW: Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology 1997;113:904-913.
20. Bockman DE, Merlino G: Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor. Gastroenterology 1992;103:1883-1892.
21. Ibelgaufts H (ed): Dictionary of Cytokines. VCH Publishers, Weinheim, 1995.
22. Nicos N (ed): Guide Book to Cytokines and Their Receptors. New York, Oxford University Press, 1994.
23. Carpenter G: Epidermal growth factor is a major growth-promoting agent in human milk. Science 1980;210:198-199.
24. Tsutsumi O, Kurachi H, Oka T: A physiological role of epidermal growth factor in male reproductive function. Science 1986;233:975-977.
25. Laurence DJ, Gusterson BA: The epidermal growth factor: A review of structural and functional relationships in the normal organism and in cancer cells. Tumor Biol 1990;11:229-261.
26. Carraway KL 3rd, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M, Lai C: Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 1997;387:512-516.
27. Chang H, Riese DJ 2nd, Gilbert W, Stern DF, McMahan UJ: Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 1997;387:509-512.
28. Davis-Fleischer KM, Besner GE: Structure and function of heparin-binding EGF-like growth factor (HB-EGF). Front Biosci 1998;3:288-299.
29. Derynck R: The physiology of transforming growth factor-α. Adv Cancer Res 1992;58:27-52.
30. Kudlow JE, Bjorge JD: TGF-α in normal physiology. Semin Cancer Biol 1990;1:293-302.
31. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 1990;10: 1969-1981.
32. Sasada R, Ono Y, Taniyama Y, Shing Y, Folkman J, Igarashi K: Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem Biophys Res Commun 1993;190:1173-1179.
33. Toyoda H, Komurasaki T, Uchida D, Morimoto S: Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 1997;326:69-75.
34. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, Hillan K, Crowley C, Brush J, Godowski PJ: Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 1997;94:9562-9567.
35. Matsubara H, Moriguchi Y, Mori Y, Masaki H, Tsutsumi Y, Shibasaki Y, Uchiyama-Tanaka Y, Fujiyama S, Koyama Y, Nose-Fujiyama A, Iba S, Tateishi E, Iwasaka T: Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-β gene expression via transcriptional and post-transcriptional mechanisms. Mol Cell Biochem 2000;212: 187-201.
36. Sarkar FH, Ball DE, Li YW, Crissman JD: Molecular cloning and sequencing of an intron of Her-2/neu (ERBB2) gene. DNA Cell Biol 1993;12:611-615.
37. Prigent SA, Lemoine NR: The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 1992;4: 1-24.
38. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA: Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 1989;86: 9193-9197.
39. Carraway KL 3rd, Cantley LC: A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling. Cell 1994;78:5-8.
40. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9:383-391.
41. Riese DJ 2nd, Stern DF: Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998;20:41-48.
42. Yamada M, Ikeuchi T, Hatanaka H: The neurotrophic action and signalling of epidermal growth factor. Prog Neurobiol 1997;51:19-37.
43. Cano E, Mahadevan LC: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 1995;20:117-122.
44. Errede B, Cade RM, Yashar BM, Kamada Y, Levin DE, Irie K, Matsumoto K: Dynamics and organization of MAP kinase signal pathways. Mol Reprod Dev 1995;42:477-485.
45. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL: MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: Upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 1997;7:67-74.
46. Schlesinger TK, Fanger GR, Yujiri T, Johnson GL: The TAO of MEKK. Front Biosci 1998;3: 1181-1186.
47. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 1995;9:726-735.
48. Floridon C, Jensen CH, Thorsen P, Nielsen O, Sunde L, Westergaard JG, Thomsen SG, Teisner B: Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation 2000;66:49-59.
49. Miettinen PJ, Huotari M, Koivisto T, Ustinov J, Palgi J, Rasilainen S, Lehtonen E, Keski-Oja J, Otonkoski T: Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development 2000;127:2617-27.
50. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor-α. J Clin Invest 1992;90:1352-1360.
51. Yamanaka Y, Friess H, Kobrin MS, Büchler M, Beger HG, Korc M: Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 1993;13:565-570.
52. Korc M, Friess H, Yamanaka Y, Kobrin M, Büchler MW, Beger HG: Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor-α and phospholipase C-γ. Gut 1994;35:1468-1473.
53. Vinter-Jensen L, Juhl CO, Teglbjaerg PS, Poulsen SS, Dajani EZ, Nexo E: Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology 1997;113:1367-1374.
54. Birk D, Gansauge F, Gansauge S, Formentini A, Lucht A, Beger HG: Serum and correspondent tissue measurements of epidermal growth factor and epidermal growth factor receptor. Clinical relevance in pancreatic cancer and chronic pancreatitis. Int J Pancreatol 1999;25: 89-96.
55. 5 Friess H, Yamanaka Y, Büchler MW, Hammer K, Kobrin M, Beger HG: A subgroup of patients with chronic pancreatitis overexpress the c-erbB-2 protooncogene. Ann Surg 1994;220: 183-192.
56. Yamanaka Y, Friess H, Kobrin MS, Büchler MW, Kunz J, Beger HG, Korc M: Overexpression of HER2/neu oncogene in human pancreatic cancer. Hum Pathol 1993;24:1127-1134.
57. Friess H, Yamanaka Y, Kobrin SM, Do DA, Büchler MW, Korc M: Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin Cancer Res 1995; 1:1413-1420.
58. Baldassarre G, Bianco C, Tortora G, Ruggiero A, Moasser M, Dmitrovsky E, Bianco AR, Ciardiello F: Transfection with a cripto antisense plasmid suppresses endogenous cripto expression and inhibits transformation in a human embryonal carcinoma cell line. Int J Cancer 1996;66:538-543.
59. Friess H, Yamanaka Y, Büchler MW, Kobrin MS, Tahara E, Korc M: Cripto, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 1994;56: 668-674.
60. Moscatelli D, Presta M, Rifkin DB: Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis and migration. Proc Natl Acad Sci USA 1986;83:2091-2095.
61. Saksela O, Moscatelli D, Rifkin DB: The opposing effects of basic fibroblast growth factor and transforming growth factor-β on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 1987;105: 957-963.
62. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
63. Klagsbrun M: The fibroblast growth factor family: Structural and biological properties. Prog Growth Factor Res 1989;1:207-235.
64. Courty J, Loret C, Chevallier B, Moenner M, Barritault D: Biochemical comparative studies between eye and brain derived growth factors. Biochemie 1987;69:511-516.
65. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115-165.
66. Demo SD, Kikuchi A, Peters KG, MacNicol AM, Muslin AJ, Williams LT: Signaling molecules that mediate the actions of FGF. Princess Takamatsu Symp 1994;24:243-249.
67. Givol D, Yayon A: Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity. FASEB J 1992;6:3362-3369.
68. Johnson DE, Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993;60:1-41.
69. Kornmann M, Beger HG, Korc M: Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 1998;17:169-175.
70. Partanen J, Vainikka S, Alitalo K: Structural and functional specificity of FGF receptors. Philos Trans R Soc Lond B Biol Sci 1993;340: 297-303.
71. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987;235:442-447.
72. Gospoderowicz D, Ferrara N, Schweigerer L, Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987;8:95-114.
73. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaku M: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type 2 in human benign prostatichyperplasia. Prostate 1990;16: 71-80.
74. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C: In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 1990;137:85-92.
75. Friess H, Kobrin MS, Korc M: Acidic and basic fibroblast growth factors and their receptors are expressed in the human pancreas. Pancreas 1992;7:737.
76. Yamanaka Y, Friess H, Büchler M, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993; 53:5289-5296.
77. Friess H, Yamanaka Y, Büchler M, Beger HG, Do DA, Kobrin MS, Korc M: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994; 144:117-128.
78. Massague J: TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791.
79. Derynck R, Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1997;1333:105-150.
80. Yingling JM, Wang XF, Bassing CH: Signaling by the transforming growth factor-β receptors. Biochim Biophys Acta 1995;1242:115-136.
81. Massague J: The transforming growth factor-β family. Rev Cell Biol 1990;6:597-641.
82. Hebda PA: Stimulatory effects of transforming growth factor-β and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J Invest Dermatol 1988;91:440-445.
83. Massague J, Cheifetz S, Laiho M, Ralph DA, Weiss FMB, Zentella A: Transforming growth factor-β. Cancer Surv 1992;12:81-103.
84. Roberts AB, Sporn MG, Assoian RK, Smith JM, Roche NS: Transforming growth factor type-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83:4167-4171.
85. Sporn MB, Roberts AB: Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 1992;119:1017-1021.
86. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β. Growth Factors 1993;8:1-9.
87. Roberts AB, Sporn MB: The transforming growth factor-β; in Sporn MB, Roberts AB (eds): Peptide Growth Factors and Their Receptors, vol 95: Handbook of Experimental Pharmacology. New York, Springer, 1990, pp 419-472.
88. Friess H, Yamanaka Y, Büchler M, Beger HG, Kobrin MS, Baldwin RL, Korc M: Enhanced expression of the type II transforming growth factor-β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 1993;53:2704-2707.
89. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68:775-785.
90. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J: Structure and expression of the membrane proteoglycan beta-glycan, a component of the TGF-β receptor system. Cell 1991;67:785-795.
91. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-1014.
92. Lopez-Casillas F, Wrana JL, Massague J: Beta-glycan presents ligand to the TGF-β signaling receptor. Cell 1993;73:1435-1444.
93. 1 in chronic pancreatitis. Digestion 1995;56:237-241.
94. 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995;108:1873-1881.
95. Van Laethem JL, Robberecht P, Resibios A, Deviere J: Transforming growth factor-β promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 1996;110:576-582.
96. 1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 2001;280:164-172.
97. Westermark B, Heldin CH: Platelet-derived growth factor in autocrine transformation. Cancer Res 1991;51:5087-5092.
98. Heldin CH, Westermark B: Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regul 1990;1:555-566.
99. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC, Wilson JS: Pancreatic stellate cells are activated by proinflammatory cytokines: Implications for pancreatic fibrogenesis. Gut 1999;44: 534-541.
100. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, Pirola RC, McCaughan GW, Ramm GA, Wilson JS: Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999;155:1087-1095.
101. Levi-Montalcini R: The nerve growth factor 35 years later. Science 1987;237:1154-1162.
102. Barbacid M: Neurotrophic factors and their receptors. Curr Opin Cell Biol 1995;7:148-155.
103. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A: Nerve growth factor: From neurotrophin to neurokine. Trends Neurosci 1996;19:514-520.
104. Levi-Montalcini R, Dal Toso R, della Valle F, Skaper SD, Leon A: Update of the NGF saga. J Neurol Sci 1995;130:119-127.
105. Friess H, Zhu ZW, di Mola FF, Kulli C, Graber HU, Andren-Sandberg A, Zimmermann A, Korc M, Reinshagen M, Büchler MW: Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 1999;230:615-624.
106. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992;26: 455-465.
107. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
108. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR: Transforming growth factor-α and epidermal growth factor in human pancreatic cancer. J Pathol 1991;163:111-116.
109. Lemoine NR, Hall PA: Growth factors and oncogenes in pancreatic cancer. Baillieres Clin Gastroenterol 1990;4:815-832.
110. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Büchler MW, Johnson GR, Korc M: Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-3962.
111. Yokoyama M, Funatomi H, Kobrin MS, Ebert M, Friess H, Büchler MW, Korc M: Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer. Int J Oncol 1995;7: 825-829.
112. Kobrin MS, Funatomi H, Friess H, Büchler MW, Stathis P, Korc M: Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994;202:1705-1709.
113. Wagner M, Luhrs H, Kloppel G, Adler G, Schmid RM: Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 1998;115:1254-1262.
114. Wagner M, Cao T, Lopez ME, Hope C, van Nostrand K, Kobrin MS, Fan HU, Büchler MW, Korc M: Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int J Cancer 1996;68: 782-787.
115. Kornmann M, Ishiwata T, Beger HG, Korc M: Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: Evidence for autocrine and paracrine actions. Oncogene 1997; 15:1417-1424.
116. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Büchler MW, Korc M: Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1995;215:309-315.
117. Kleeff J, Ishiwata T, Kumbasar A, Friess H, Büchler MW, Lander AD, Korc M: The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998;102:1662-1673.
118. Ishiwata T, Friess H, Büchler MW, Lopez ME, Korc M: Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 1998; 153:213-222.
119. Wagner M, Lopez ME, Cahn M, Korc M: Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. Gastroenterology 1998;114:798-807.
120. Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G: Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 2000;60:7163-7169.
121. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T: Smad 1 and Smad 5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 1997;238:574-580.
122. 1 cDNA in a mammary adenocarcinoma: In vitro and in vivo effects. Growth Factors 1991;5:305-316.
123. Naef M, Ishiwata T, Friess H, Büchler MW, Gold LI, Korc M: Differential localization of transforming growth factor-β isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer 1997;71:131-137.
124. Friess H, Yamanaka Y, Büchler M, Ebert M, Beger HG, Gold LI, Korc M: Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105: 1846-1856.
125. Baldwin RL, Friess H, Yokoyama M, Lopez ME, Kobrin MS, Büchler MW, Korc M: Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition. Int J Cancer 1996;67: 283-288.
126. 1 in COLO-357 cells. J Biol Chem 1998;273: 7495-7500.
127. Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ: Induction of p21waf1 expression and growth inhibition by transforming growth factor-β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997;57:3929-3934.
128. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, Massague J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996;381:620-623.
129. Lu Z, Friess H, Graber HU, Guo X, Schilling M, Zimmermann A, Korc M, Büchler MW: Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. Dig Dis Sci 1997;42: 2054-2063.
130. Wagner M, Kleeff J, Lopez ME, Bockman I, Massaque J, Korc M: Transfection of the type I TGF-β receptor restores TGF-β responsiveness in pancreatic cancer. Int J Cancer 1998; 78:255-260.
131. Whitman M: Signal transduction. Feedback from inhibitory SMADs. Nature 1997;389: 549-551.
132. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271:350-353.
133. Dai JL, Turnacioglu KK, Schutte M, Sugar AY, Kern SE: Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res 1998;58:4592-4597.
134. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J: Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 1996;383:832-836.
135. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA Jr, Meltzer PS, Hahn SA, Kern SE: DPC4 gene in various tumor types. Cancer Res 1996;56:2527-2530.
136. 1 represses proliferation of pancreatic carcinoma cells which correlates with Smad 4-independent inhibition of ERK activation. Oncogene 2000;19:4531-4541.
137. Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE: Genetic alterations of the transforming growth factor-β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 1998;58:5329-5332.
138. Villanueva A, Garcia C, Paules AB, Vicente M, Megias M, Reyes G, de Villalonga P, Agell N, Lluis F, Bachs O, Capella G: Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Oncogene 1998;17:1969-1978.
139. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K: A transforming growth factor-β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995;55:5545-5547.
140. Iacopetta BJ, Welch J, Soong R, House AK, Zhou XP, Hamelin R: Mutation of the transforming growth factor-β type II receptor gene in right-sided colorectal cancer: Relationship to clinicopathological features and genetic alterations. J Pathol 1998;184:390-395.
141. Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J, Markowitz S: Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998;58:3101-3104.
142. Kleeff J, Maruyama H, Friess H, Büchler MW, Falb D, Korc M: Smad 6 suppresses TGF-β-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Biochem Biophys Res Commun 1999;255:268-273.
143. Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Büchler MW, Falb D, Korc M: The TGF-β signaling inhibitor Smad 7 enhances tumorigenicity in pancreatic cancer. Oncogene 1999;18:5363-5372.
144. Kleeff J, Ishiwata T, Friess H, Büchler MW, Korc M: Concomitant overexpression of activin/inhibin β subunits and their receptors in human pancreatic cancer. Int J Cancer 1998; 77:860-868.
145. Kleeff J, Maruyama H, Ishiwata T, Sawhney H, Friess H, Büchler MW, Korc M: Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 1999;116:1202-1216.
146. Bold RJ, Ishizuka J, Rajaraman S, Perez-Polo JR, Townsend CM Jr, Thompson JC: Nerve growth factor as a mitogen for a pancreatic carcinoid cell line. J Neurochem 1995;64: 2622-2628.
147. Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE: Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. Cancer Res 1995; 55:2212-2219.
148. Geldof AA, De Kleijn MA, Rao BR, Newling DW: Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells. J Cancer Res Clin Oncol 1997; 123:107-112.
149. Pour PM, Egami H, Takiyama Y: Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology 1991;100: 529-536.
150. Gudjonsson B: Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-2303.
151. Bookman DE, Büchler MW, Beger HG: Morphology of pancreatic cancer: Involvement of nerves; in Beger HG, Büchler MW, Schoenberg M (eds): Cancer of the Pancreas. Ulm, Universitätsverlag Ulm GmbH, 1996, pp 99-108.
152. Zhu Z, Friess H, diMola FF, Zimmermann A, Graber HU, Korc M, Büchler MW: Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J Clin Oncol 1999;17:2419-2428.
153. Zhu Z, Wang L, Kleeff J, Bogardus T, Korc M, Büchler MW, Friess H: Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 2001;7:105-112.
154. Ebert M, Yokoyama M, Friess H, Kobrin MS, Büchler MW, Korc M: Induction of platelet-derived growth factor A and B chains and overexpression of their receptors in human pancreatic cancer. Int J Cancer 1995;62:529-535.
155. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M: Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-2011.
156. Lee AV, Yee D: Insulin-like growth factors and breast cancer. Biomed Pharmacother 1995;49:415-421.
157. Wetterau LA, Moore MG, Lee KW, Shim ML, Cohen P: Novel aspects of the insulin-like growth factor binding proteins. Mol Genet Metab 1999;68:161-181.
158. Roberts CT Jr, Leroith D: Molecular aspects of insulin-like growth factors, their binding proteins and receptors. Baillieres Clin Endocrinol Metab 1988;2:1069-1085.
159. el-Roeiy A, Chen X, Roberts VJ, Shimasakai S, Ling N, LeRoith D, Roberts CT Jr, Yen SS: Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 1994;78:1488-1496.
160. Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T, Shizume K: Insulin-like growth factor I and transforming growth factor-α as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 1990;50:103-107.
161. Evans JD, Eggo MC, Donovan IA, Bramhall SR, Neoptolemos JP: Serum levels of insulin-like growth factors (IGF-I and IGF-II) and heir binding protein (IGFBP-3) are not elevated in pancreatic cancer. Int J Pancreatol 1997;22:95-100.
162. Ishiwata T, Bergmann U, Kornmann M, Lopez M, Beger HG, Korc M: Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas 1997; 15:367-373.